Coronavirus: Regeneron antibody therapy success goes 'against the grain' of similar trials

Sir Simon Stevens, chief of NHS England, said that hospitals would 'gear up for a new category of treatments' after Oxford's trial showed the Regeneron injection could cut death risk by a fifth.